Globus Medical Inc.
Organization details
- Legal name
- Globus Medical Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Audubon
- Headquarters state / province
- Pennsylvania
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- GMED
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0001237831
- EIN
- 04-3744954
- Wikidata ID
- Q18344949
Board of directors
-
Ann D. Rhoads · DirectorSince 2023
-
Dan Lemaitre · DirectorSince 2023
-
Dan Wolterman · DirectorSince 2023
-
Daniel T. Scavilla · Director · President, CEOSince 2023
-
David C. Paul · Director · Executive ChairmanSince 2023
-
David D. Davidar · DirectorSince 2023
-
James R. Tobin · DirectorSince 2023
-
John A. DeFord · DirectorSince 2023
-
Keith W. Pfeil · Director · President, CEOSince 2025
-
Leslie Norwalk V · DirectorSince 2023
-
Robert Andrew Douglas · DirectorSince 2023
-
Stephen T. Zarrilli · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 3, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
91.3%
-
96.9%
Board connections
7 of this board's directors also sit on 10 other boards. 7 are in the same sector.
-
Arvinas Inc. Same sectorvia Leslie Norwalk V
- via Leslie Norwalk V
-
DENTSPLY SIRONA Inc. Same sectorvia Daniel T. Scavilla
-
Hyperfine Inc. Same sectorvia Dan Wolterman
-
Maravai LifeSciences Holdings Inc. Same sectorvia John A. DeFord
-
Neurocrine Biosciences Inc. Same sectorvia Leslie Norwalk V
- via John A. DeFord
-
QuidelOrtho Corporation Same sectorvia Ann D. Rhoads
-
TransMedics Group Inc. Same sectorvia James R. Tobin
- via Stephen T. Zarrilli
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $16,020,381
- 13 sales by 7 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 10, 2026 | James R. Tobin Director | Option exercise | +15,000 | $65.05 | $975,750 |
| Nov 10, 2026 | James R. Tobin Director | Option exercise | +21,458 | $53.27 | $1,143,068 |
| Nov 10, 2026 | James R. Tobin Director | Option exercise | +5,208 | $43.58 | $226,965 |
| Nov 10, 2026 | James R. Tobin Director | Open-market sale | −37,662 | $75.10 | $2,828,510 |
| Nov 10, 2026 | James R. Tobin Director | Open-market sale | −4,004 | $75.68 | $303,037 |
| Nov 4, 2026 | Ann D. Rhoads Director | Open-market sale | −5,000 | $85.00 | $425,000 |
| Sep 15, 2026 | James R. Tobin Director | Option exercise | +15,000 | $53.75 | $806,250 |
| Sep 15, 2026 | James R. Tobin Director | Option exercise | +15,000 | $63.68 | $955,200 |
| Sep 15, 2026 | James R. Tobin Director | Open-market sale | −30,000 | $74.58 | $2,237,400 |
| Aug 18, 2026 | Stephen T. Zarrilli Director | Option exercise | +25,000 | $53.27 | $1,331,750 |
| Aug 18, 2026 | Stephen T. Zarrilli Director | Open-market sale | −25,000 | $87.04 | $2,176,000 |
| Jul 27, 2026 | David D. Davidar Director | Gift | −2,500 | — | — |
| Jun 5, 2026 | David D. Davidar Director | Option exercise | +25,000 | $26.27 | $656,750 |
| Jun 5, 2026 | David D. Davidar Director | Open-market sale | −25,000 | $80.76 | $2,019,000 |
| Jun 4, 2026 | Ann D. Rhoads Director | Option exercise | +25,000 | $26.27 | $656,750 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Globus Medical Inc.
Who is the CEO of Globus Medical Inc.?
Daniel T. Scavilla is Globus Medical Inc.'s President, CEO.
How many directors are on Globus Medical Inc.'s board?
Globus Medical Inc.'s board has 12 directors: Ann D. Rhoads, Dan Lemaitre, Dan Wolterman, Daniel T. Scavilla, David C. Paul, David D. Davidar, James R. Tobin, John A. DeFord, Keith W. Pfeil, Leslie Norwalk V and 2 others.
Are Globus Medical Inc. insiders buying or selling shares?
Over the last 12 months, Globus Medical Inc. insiders made no open-market purchases and sold $16.0 million of shares in 13 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="globus-medical-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.